Calithera Biosciences, Inc. (CALA) Q2 2022 Earnings Call

Investor webinar replay

Replay transcript excerpt

and welcome to the Califera Biosciences Second Quarter 2022 Earnings Conference Hall. At this time, all participants are in listen-only mode. After the speaker's presentation, there will be a question-and-answer session. As a reminder, this call may be recorded. I would like to turn the call over to Stephanie Wong, CFO. You may begin. Thank you, Operator. Good afternoon, everyone, and welcome to our Second Quarter 2022 Conference Hall. Joining me today are Susan Molyneux, Founder, President, and CEO of and Emil Curiaco, Chief Medical Officer. Earlier this afternoon, we issued a press release, which included an overview of the second quarter 2022 financial and operational results, which can be accessed through our website at Caledonia.com. Before we begin, I would like to remind you that today's discussion will include statements about our future expectations, plans, and prospects that constitute forward-looking statements for purposes of the safe harbor provisions under the private security litigation reform act of 1995. Actual results may differ materially from those indicated by these forward-looking statements as a result of various important factors, including those discussed in the respective sections of the periodic filing for the FCC. In addition, any forward-looking statements represent our views only as of today and should not be relied upon as representing our views as of any subsequent date. While we may elect to update these forward-looking statements at some point in the future, we specifically disclaim any obligation to do so even if our views change. Please note that this call is being recorded, and with that, I'll turn the call over to Susan. Thanks, Stephanie. Good afternoon, everyone, and thank you for joining us for today's conference call. When we...